Ci Investments Decreased By $2.37 Million Its Bristol Myers Squibb Co (BMY) Stake; Cogentix Medical (CGNT) Sellers Decreased By 5.09% Their Shorts

May 29, 2017 - By Clifton Ray

Cogentix Medical Incorporated (NASDAQ:CGNT) had a decrease of 5.09% in short interest. CGNT’s SI was 50,300 shares in May as released by FINRA. Its down 5.09% from 53,000 shares previously. With 64,000 avg volume, 1 days are for Cogentix Medical Incorporated (NASDAQ:CGNT)’s short sellers to cover CGNT’s short positions. The SI to Cogentix Medical Incorporated’s float is 0.26%. The stock decreased 2.04% or $0.04 on May 26, reaching $1.68. About 36,736 shares traded. Cogentix Medical Inc (NASDAQ:CGNT) has risen 83.33% since May 29, 2016 and is uptrending. It has outperformed by 66.63% the S&P500.

Ci Investments Inc decreased Bristol Myers Squibb Co (BMY) stake by 2.11% reported in 2016Q4 SEC filing. Ci Investments Inc sold 40,900 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Ci Investments Inc holds 1.90 million shares with $110.96M value, down from 1.94M last quarter. Bristol Myers Squibb Co now has $88.23B valuation. The stock decreased 0.77% or $0.42 on May 26, reaching $53.97. About 4.97M shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since May 29, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.16, from 1.13 in 2016Q3. It dived, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. 1.14 billion shares or 1.92% more from 1.12 billion shares in 2016Q3 were reported. Bancorporation Of America Corp De owns 0.15% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 12.22 million shares. Windward Cap Management Company Ca stated it has 21,136 shares or 0.24% of all its holdings. Benchmark Advisors has invested 4.37% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Ironbridge Cap Ltd Partnership has invested 0.02% in Bristol-Myers Squibb Co (NYSE:BMY). North Star Asset Mgmt holds 0.08% or 13,003 shares in its portfolio. Venbio Select Advisor Limited Com holds 3.36% in Bristol-Myers Squibb Co (NYSE:BMY) or 285,000 shares. Fulton Breakefield Broenniman reported 88,465 shares. Moreover, Tompkins Fincl Corporation has 0.08% invested in Bristol-Myers Squibb Co (NYSE:BMY). Janney Montgomery Scott Limited Liability Company reported 606,796 shares. Investor Ab has 0.02% invested in Bristol-Myers Squibb Co (NYSE:BMY). Morgan Stanley invested 0.27% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Eaton Vance reported 3.68M shares stake. Cape Cod Five Cents Natl Bank invested in 31,454 shares or 0.32% of the stock. Loomis Sayles And Limited Partnership holds 1.96% or 13.65 million shares. Vaughan David Invs Inc Il stated it has 0.04% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY).

Analysts await Bristol-Myers Squibb Co (NYSE:BMY) to report earnings on July, 27. They expect $0.73 earnings per share, up 5.80% or $0.04 from last year’s $0.69 per share. BMY’s profit will be $1.19B for 18.48 P/E if the $0.73 EPS becomes a reality. After $0.84 actual earnings per share reported by Bristol-Myers Squibb Co for the previous quarter, Wall Street now forecasts -13.10% negative EPS growth.

Ci Investments Inc increased Pepsico Inc (NYSE:PEP) stake by 40,200 shares to 903,897 valued at $94.58M in 2016Q4. It also upped Ishares Tr (IEF) stake by 103,360 shares and now owns 158,573 shares. Twenty First Centy Fox Inc (NASDAQ:FOX) was raised too.

Among 17 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 7 Hold. Therefore 41% are positive. Bristol-Myers Squibb Company had 37 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has “Hold” rating given on Thursday, August 11 by Berenberg. The rating was maintained by Jefferies on Thursday, July 14 with “Hold”. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Underweight” rating by Atlantic Securities on Friday, December 18. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Outperform” rating by Robert W. Baird on Wednesday, April 26. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has “Buy” rating given on Friday, January 22 by Berenberg. On Friday, September 9 the stock rating was maintained by Barclays Capital with “Equal-Weight”. UBS maintained Bristol-Myers Squibb Co (NYSE:BMY) on Friday, April 29 with “Buy” rating. The rating was maintained by Jefferies with “Hold” on Tuesday, March 15. The rating was initiated by Societe Generale with “Sell” on Wednesday, April 6. The firm has “Outperform” rating by Credit Suisse given on Monday, May 9.

Since February 27, 2017, it had 1 insider purchase, and 6 sales for $9.91 million activity. The insider ANDREOTTI LAMBERTO sold $1.81M. 5,000 shares were sold by Schmukler Louis S, worth $282,470 on Friday, March 17. Samuels Theodore R. II bought $681,240 worth of stock or 12,000 shares. Caldarella Joseph C sold $463,779 worth of stock or 8,096 shares. 92,405 shares were sold by LEUNG SANDRA, worth $5.27M on Friday, March 3.

Among 2 analysts covering Cogentix Medical (NASDAQ:CGNT), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Cogentix Medical had 3 analyst reports since November 5, 2015 according to SRatingsIntel. TH Capital upgraded the shares of CGNT in report on Thursday, November 5 to “Buy” rating. Roth Capital upgraded Cogentix Medical Inc (NASDAQ:CGNT) on Thursday, November 5 to “Buy” rating. Roth Capital downgraded Cogentix Medical Inc (NASDAQ:CGNT) on Friday, May 6 to “Neutral” rating.